Cryder Capital Partners LLP Trims Position in HCA Healthcare, Inc. $HCA

Key Points

• Cryder Capital Partners LLP trimmed its stake in HCA by 12.3% in Q4, selling 74,614 shares and now holding 530,145 shares worth about $247.5 million, which represents ~14.6% of Cryder’s portfolio and is its second-largest position.
• Several analysts have cut price targets recently (e.g., TD Cowen to $500, Wells Fargo to $436, RBC to $534), but consensus remains a Moderate Buy with an average price target of $517.82 (16 Buys, 7 Holds, 1 Sell).
• HCA reported Q earnings of $7.15 (missed by $0.04) on $19.11 billion revenue, set FY2026 guidance of 29.10–31.50 EPS (street avg ~30.05), and declared a $0.78 quarterly dividend (≈0.7% yield).

Cryder Capital Partners LLP cut its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 12.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 530,145 shares of the company's stock after selling 74,614 shares during the quarter. HCA Healthcare accounts for approximately 14.6% of Cryder Capital Partners LLP's investment portfolio, making the stock its 2nd largest position. Cryder Capital Partners LLP owned 0.23% of HCA Healthcare worth $247,503,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of HCA. Palisade Asset Management LLC purchased a new position in shares of HCA Healthcare in the third quarter valued at $26,000. Holos Integrated Wealth LLC purchased a new position in shares of HCA Healthcare in the fourth quarter valued at $29,000. Ares Financial Consulting LLC purchased a new position in shares of HCA Healthcare in the fourth quarter valued at $31,000. JPL Wealth Management LLC purchased a new position in shares of HCA Healthcare in the third quarter valued at $33,000. Finally, Aventura Private Wealth LLC bought a new stake in HCA Healthcare in the fourth quarter worth $34,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HCA has been the subject of a number of analyst reports. TD Cowen lowered their price target on HCA Healthcare from $561.00 to $500.00 and set a "buy" rating for the company in a research report on Monday, April 27th. Jefferies Financial Group restated a "buy" rating and issued a $525.00 price target on shares of HCA Healthcare in a research report on Friday, April 24th. Wells Fargo & Company lowered their price target on HCA Healthcare from $481.00 to $436.00 and set an "equal weight" rating for the company in a research report on Monday, April 27th. Royal Bank Of Canada lowered their price target on HCA Healthcare from $593.00 to $534.00 and set an "outperform" rating for the company in a research report on Monday, April 27th. Finally, Wall Street Zen lowered HCA Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $517.82.

HCA Healthcare Price Performance

Shares of HCA opened at $428.94 on Wednesday. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The company has a 50-day moving average of $495.58 and a 200 day moving average of $486.47. The firm has a market capitalization of $95.16 billion, a price-to-earnings ratio of 14.75, a PEG ratio of 1.36 and a beta of 1.18.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts' consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the previous year, the business earned $6.45 EPS. The company's quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 30.05 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is presently 10.73%.

Insider Activity at HCA Healthcare

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the company's stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president directly owned 44,379 shares of the company's stock, valued at $22,411,395. This represents a 8.27% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Michael R. Mcalevey sold 1,694 shares of the business's stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the sale, the executive vice president owned 8,853 shares in the company, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 13,714 shares of company stock valued at $7,050,460 over the last quarter. 1.50% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.